Drug Discovery · Boston, MA · Founded 2025 · Privately Held (backing)
Operator of a clinical-stage biotechnology company intended to develop novel therapies for pulmonary arterial hypertension through innovative molecular mechanisms. PAhR Therapeutics is based in Boston, MA and was founded in 2025. It was valued at $25 million at its seed round in Jul 2025, the last priced event on record. It has raised $14 million across 1 recorded round; the latest was a $14 million seed round in Jul 2025.
PMV mark · valuation
$25.0M
Oct 2026
Priced at
its seed round
Jul 2025
Total raised
$14.0M
Last round
Seed Round
Jul 2025
Team — not yet on record
No current team members for PAhR Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of PAhR Therapeutics with a free account
·Watch PAhR Therapeutics: the Monday email on marks, rounds and moves
